Boenning & Scattergood’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $939K | Buy |
14,155
+1,125
| +9% | +$74.6K | 0.15% | 160 |
|
|
2022
Q3 | $715K | Sell |
13,030
-976
| -7% | -$53.6K | 0.15% | 165 |
|
|
2022
Q2 | $925K | Sell |
14,006
-149
| -1% | -$9.84K | 0.17% | 142 |
|
|
2022
Q1 | $939K | Buy |
14,155
+1,794
| +15% | +$119K | 0.15% | 160 |
|
|
2021
Q4 | $720K | Buy |
12,361
+84
| +0.7% | +$4.89K | 0.12% | 202 |
|
|
2021
Q3 | $737K | Buy |
12,277
+2,640
| +27% | +$158K | 0.13% | 187 |
|
|
2021
Q2 | $577K | Buy |
9,637
+20
| +0.2% | +$1.2K | 0.1% | 213 |
|
|
2021
Q1 | $478K | Buy |
9,617
+150
| +2% | +$7.46K | 0.09% | 240 |
|
|
2020
Q4 | $473K | Buy |
9,467
+1,058
| +13% | +$52.9K | 0.1% | 212 |
|
|
2020
Q3 | $461K | Buy |
8,409
+800
| +11% | +$43.9K | 0.11% | 198 |
|
|
2020
Q2 | $402K | Buy |
+7,609
| New | +$402K | 0.11% | 203 |
|